Before that, as Regional Director at Nevro, he doubled division revenue and contributed to the successful U.S. launch of the HF10 therapy. Earlier in his career, Mr. Thiyagalingam held senior ...

These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the NuVasive and Nevro businesses and our ability to successfully integrate and ...

Salvia BioElectronics has raised 26 million euros ($30 million) in new financing to fund development of a neurostimulation therapy for chronic migraine. Neurostimulation has been proven as an ...

The first subject had the device implanted in a procedure lasting around an hour, with the neurostimulator attached to the wall of the body cavity in the abdomen. The delivery of electrical pulses ...

The Modulus device is an extension of Globus’ existing Modulus ALIF interbody spacer system. 3. Globus Medial completed its acquisition of Nevro, a spinal cord stimulator company. The deal was first ...

Nearly a decade after the FDA approved the Infinity deep brain stimulation (DBS) system, it’s still the smallest nonrechargable device of its kind on the market. Months after St. Jude Medical won that ...

Visit a quote page and your recently viewed tickers will be displayed here.

Join us in-person or virtually May 17, 2025, at Butler University - Hinkle Fieldhouse to raise awareness and funds to support the epilepsy community. With each step taken and dollar raised, we're ...

You will be redirected to our submission process. Substance use disorders (SUDs) affect individuals across various demographics, yet significant disparities persist in access to and effectiveness of ...